← Back to catalogue

Leander

FDA UDI

Class I (US FDA UDI)

by Leander, Llc

Identity

Trade Name
Leander FDA UDI
Generic Name
Examination/treatment table, line-powered FDA UDI
Device Name
Examination/treatment motorized table with some articulated sections that can be adjusted into various accommodations for patient comfort and/or treatment. The height of the table surface is also power-adjusted. It is typically used by physical therapists and chiropractors. FDA UDI
Model / Reference
LT-950 FDA UDI
Description
Examination/treatment motorized table with some articulated sections that can be adjusted into various accommodations for patient comfort and/or treatment. The height of the table surface is also power-adjusted. It is typically used by physical therapists and chiropractors. FDA UDI

Identifiers

Primary DI / UDI-DI
G509SERIES9500 FDA UDI
FDA Product Code
LGX FDA UDI
GMDN Term
Examination/treatment table, line-powered FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
878.4960 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Examination/treatment table, line-powered

Leander by Leander, Llc — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Examination/treatment table, line-powered.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Leander, Llc

Sources (1)

  • FDA UDI 08f33d15-1e9e-4e70-89c5-8747bdd17c0a 33 fields · synced May 30, 2026